AstraZeneca shares up after breast cancer drug shows positive results
Postive cancer trial resultsPotentially increases patient poolNew standard of careShares in AstraZeneca (AZN) got a further boost today, rising 2% after posting positive late-stage trial results for breast cancer treatment Enhertu...
29 April 2024